AKT1 and glioblastoma: Shikonin demonstrates inhibitory effects on the proliferation, migration, and invasion of U87 and U251 cells in vitro. Additionally, Shikonin can inhibit the migration and invasion of GBM cells by targeting phosphorylated β-Catenin and phosphorylated PI3K/Akt signaling pathways (92)